Amgen ( (AMGN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amgen shares slipped as analysts kept their cautious stance despite the latest company update, a sign that Wall Street remains unconvinced about near‑term upside. Investor sentiment stayed muted even though expectations for future growth did not deteriorate.
Price targets were nudged slightly higher, but ratings were left unchanged. Amgen also inched up its 2026 revenue and earnings outlook, detailed a $2.6 billion capex plan, capped buybacks at $3 billion, and reported progress on its MariTide obesity studies and other Phase 3 programs.
More about Amgen
YTD Price Performance: 6.52%
Average Trading Volume: 2,726,330
Technical Sentiment Signal: Buy
Current Market Cap: $186.9B
For further insights into AMGN stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.